We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$475B
AUM Growth
+$26B
Cap. Flow
-$6.36B
Cap. Flow %
-1.34%
Top 10 Hldgs %
16.2%
Holding
2,616
New
108
Increased
1,286
Reduced
995
Closed
102

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.54B
2
VIPS icon
Vipshop
VIPS
+$825M
3
HON icon
Honeywell
HON
+$813M
4
EL icon
Estee Lauder
EL
+$804M
5
GE icon
GE Aerospace
GE
+$787M

Sector Composition

Rank Sector Weight
1 Healthcare 22.49%
2 Consumer Discretionary 15.06%
3 Financials 13.94%
4 Technology 11.82%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIBC
1326
DELISTED
WILSHIRE BANCORP INC
WIBC
$7.76M ﹤0.01%
+672,320
New +$7.65M
BCRX icon
1327
BioCryst Pharmaceuticals
BCRX
$2.51B
$7.74M ﹤0.01%
750,100
-356,989
-32% -$3.55M
GTN icon
1328
Gray Television
GTN
$520M
$7.74M ﹤0.01%
474,700
+456,500
+2,508% +$7.15M
AN icon
1329
AutoNation
AN
$6.89B
$7.71M ﹤0.01%
129,311
IQV icon
1330
IQVIA
IQV
$39.8B
$7.68M ﹤0.01%
111,866
+20,666
+23% +$1.41M
GRMN
1331
Garmin
GRMN
$60.2B
$7.68M ﹤0.01%
206,590
-2,400
-1% -$87.3K
DXYN
1332
DELISTED
Dixie Group Inc
DXYN
$7.64M ﹤0.01%
1,461,520
-21,200
-1% -$144K
HBMD
1333
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$7.64M ﹤0.01%
578,310
-2,550
-0.4% -$34.4K
INDA icon
1334
iShares MSCI India ETF
INDA
$6.58B
$7.61M ﹤0.01%
276,200
+25,500
+10% +$713K
I
1335
DELISTED
INTELSAT S. A.
I
$7.6M ﹤0.01%
1,827,370
-125,100
-6% -$695K
CPRT icon
1336
Copart
CPRT
$27.2B
$7.6M ﹤0.01%
1,598,752
-2,848
-0.2% -$13.2K
RIG icon
1337
Transocean
RIG
$6.39B
$7.58M ﹤0.01%
612,280
-18,500
-3% -$267K
SNMX
1338
DELISTED
Senomyx, Inc.
SNMX
$7.58M ﹤0.01%
2,010,585
+67,170
+3% +$307K
CG icon
1339
Carlyle Group
CG
$18.3B
$7.56M ﹤0.01%
484,000
+2,300
+0.5% +$40.9K
HAIN icon
1340
Hain Celestial
HAIN
$53.9M
$7.5M ﹤0.01%
185,648
+68,705
+59% +$3.12M
DF
1341
DELISTED
Dean Foods Company
DF
$7.48M ﹤0.01%
435,928
-675,860
-61% -$12.2M
DBI icon
1342
Designer Brands
DBI
$312M
$7.47M ﹤0.01%
313,217
-43,745
-12% -$1.05M
CLB icon
1343
Core Laboratories
CLB
$569M
$7.47M ﹤0.01%
68,700
-11,105
-14% -$1.27M
WBD icon
1344
Warner Bros
WBD
$69.6B
$7.4M ﹤0.01%
277,320
-10
-0% -$289
HHH icon
1345
Howard Hughes
HHH
$4.04B
$7.39M ﹤0.01%
68,506
+2,603
+4% +$300K
CSRA
1346
DELISTED
CSRA Inc.
CSRA
$7.31M ﹤0.01%
+243,804
New +$6.99M
ESL
1347
DELISTED
Esterline Technologies
ESL
$7.31M ﹤0.01%
90,270
-1,020
-1% -$83.2K
WFC.WS
1348
DELISTED
Wells Fargo & Company Ws
WFC.WS
$7.28M ﹤0.01%
355,275
GGAL icon
1349
Galicia Financial Group
GGAL
$7.23B
$7.28M ﹤0.01%
268,780
+8,590
+3% +$207K
NKTR icon
1350
Nektar Therapeutics
NKTR
$2.57B
$7.2M ﹤0.01%
28,480
+3,267
+13% +$672K

Similar funds

T. Rowe Price Associates's Q4 2015 Portfolio in Review

As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
  • T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
  • T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
  • T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
  • T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
  • T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.

Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.